US equities
|
SPCX
$158.37
▲+7.16%
MU
$915.41
▲+2.16%
NVDA
$221.13
▲+2.15%
TSLA
$386.39
▲+3.39%
META
$701.77
▲+1.08%
SNDK
$1,378.42
▲+0.96%
AMD
$553.95
▲+3.59%
AAPL
$343.88
▲+1.29%
SPCX
$158.37
▲+7.16%
MU
$915.41
▲+2.16%
NVDA
$221.13
▲+2.15%
TSLA
$386.39
▲+3.39%
META
$701.77
▲+1.08%
SNDK
$1,378.42
▲+0.96%
AMD
$553.95
▲+3.59%
AAPL
$343.88
▲+1.29%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Parse Biosciences
Parse Biosciences Launches Evercode MAX, Enabling Researchers to Profile More Cells and Samples with Greater Flexibility
October 20, 2026
From
Parse Biosciences
Via
Business Wire
Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network
July 29, 2026
From
Parse Biosciences
Via
Business Wire
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network
July 15, 2026
From
Parse Biosciences
Via
Business Wire
Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station
June 29, 2026
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Launches the Next Generation of its Immune Profiling Kits
June 10, 2026
From
Parse Biosciences
Via
Business Wire
Parse Biosciences and bit.bio Announce Landmark Alliance
May 27, 2026
From
Parse Biosciences
Via
Business Wire
Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
March 31, 2026
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis
January 22, 2026
From
Parse Biosciences
Via
Business Wire
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
January 20, 2026
From
Parse Biosciences
Via
Business Wire
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale
December 19, 2025
From
Parse Biosciences
Via
Business Wire
Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
December 11, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Launches Evercode Whole Blood Fixation
December 04, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Announces FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
November 18, 2025
From
Parse Biosciences
Via
Business Wire
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
November 12, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
October 09, 2025
From
Parse Biosciences
Via
Business Wire
Tempus Joins Parse Biosciences’ Certified Service Provider Network
October 08, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Expands Global Access by Certifying Single Cell Discoveries as a Service Provider
September 30, 2025
From
Parse Biosciences
Via
Business Wire
Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas
September 15, 2025
From
Parse Biosciences
Via
Business Wire
Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research
July 10, 2025
From
Parse Biosciences
Via
Business Wire
Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella
July 08, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer's and Parkinson’s Single Cell Datasets
June 25, 2025
From
Parse Biosciences
Via
Business Wire
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies
June 12, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 02, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Expands Global Reach with the South Australian Genomics Centre as Certified Service Provider
March 20, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
March 04, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
February 19, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
February 04, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
January 07, 2025
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network
December 19, 2024
From
Parse Biosciences
Via
Business Wire
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications
December 12, 2024
From
Parse Biosciences
Via
Business Wire
